This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Aripiprazole Therapy for Nicotine Dependence

Sriram Ramaswamy, MD; Subhash C. Bhatia, MD

Published: February 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Methylphenidate is a piperidine derivative, structurallyrelated to amphetamines. It reaches peak blood concentrationin 2 hours and has a short half-life of 1 to 2hours. Its onset of action occurs shortly after dosing, andit can cause increased wakefulness, energy, alertness, andphysical and mental performance. Its side effects includeanorexia, weight loss, slow growth, insomnia, dysphoria,tics, and psychosis.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 8

Quick Links: Addiction , Substance Use Disorders


Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...